#BEGIN_DRUGCARD DB01669

# AHFS_Codes:
Not Available

# ATC_Codes:
J01FG01

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
21411-53-0

# ChEBI_ID:
Not Available

# Chemical_Formula:
C28H35N3O7

# Chemical_IUPAC_Name:
(10R,11R,21S)-21-hydroxy-11,19-dimethyl-10-(propan-2-yl)-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.0^{3,7}]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Pristinamycin IIA is a macrolide antibiotic. It is a member of the streptogramin A group of antibiotics and one component of pristinamycin (the other being pristinamycin IA). It is produced by Streptomyces graminofaciens and other bacteria.

# Dosage_Forms:
Not Available

# Drug_Category:
Anti-Bacterial Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Poorly soluble in water

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Virginiamycin M1

# HET_ID:
VIR

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C28H35N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5,7-10,13,16-17,19-20,26,32H,6,11-12,14-15H2,1-4H3,(H,29,34)/b7-5+,10-9+,18-13+/t19-,20-,26-/m1/s1

# InChI_Key:
InChIKey=DAIKHDNSXMZDCU-FQTGFAPKSA-N

# Indication:
For the treatment of bacterial infections.

# KEGG_Compound_ID:
C11299

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1669

# Mechanism_Of_Action:
Virginiamycin M1 is a macrocyclic lactone antibiotic that acts syngeristically with the structurally unrelated cyclic depsipeptides more commonly known as the virginiamycins B (ostreogrycin B or streptogramin B) and S to inhibit peptide elongation. This is achieved by blocking formation of a peptide bond between the growing peptide chain (peptidyl-tRNA) linked to the 50S ribosome and aminoacyl-tRNA. Virginiamycin M1 has proven to be highly active against Gram positive bacteria, particularly methicillin-resistant S. aureus.

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
525.5934

# Molecular_Weight_Mono:
525.247500489

# Organisms_Affected:
Bacteria

# PDB_Experimental_ID:
1KHR

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.6

# Predicted_LogS:
-3.9

# Predicted_Water_Solubility:
6.01e-02 g/l

# Primary_Accession_No:
DB01669

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
Not Available

# PubChem_Substance_ID:
Not Available

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03225

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)C2=COC(=N2)CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Mikamycin A
Ostreogrycin A
Pristinamycin IIA
Streptogramin A

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:23 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Pristinamycin_IIA

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L12033

# Drug_Target_1_GenBank_ID_Protein:
433715

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
vatD

# Drug_Target_1_Gene_Sequence:
>630 bp
ATGGGTCCGAATCCTATGAAAATGTATCCTATAGAAGGAAACAAATCAGTACAATTTATC
AAACCTATTTTAGAAAAATTAGAAAATGTTGAGGTTGGAGAATACTCATATTATGATTCT
AAGAATGGAGAAACTTTTGATAAGCAAATTTTATATCATTATCCAATCTTAAACGATAAG
TTAAAAATAGGTAAATTTTGCTCAATAGGACCAGGTGTAACTATTATTATGAATGGAGCA
AATCATAGAATGGATGGCTCAACATATCCATTTAATTTATTTGGTAATGGATGGGAGAAA
CATATGCCAAAATTAGATCAACTACCTATTAAGGGGGATACAATAATAGGTAATGATGTA
TGGATAGGAAAAGATGTTGTAATTATGCCAGGAGTAAAAATCGGGGATGGTGCAATAGTA
GCTGCTAATTCTGTTGTTGTAAAAGATATAGCGCCATACATGTTAGCTGGAGGAAATCCT
GCTAACGAAATAAAACAAAGATTTGATCAAGATACAATAAATCAGCTGCTTGATATAAAA
TGGTGGAATTGGCCAATAGACATTATTAATGAGAATATAGATAAAATTCTTGATAATAGC
ATCATTAGAGAAGTCATATGGAAAAAATGA

# Drug_Target_1_General_Function:
Involved in acyltransferase activity

# Drug_Target_1_General_References:
8257133	Rende-Fournier R, Leclercq R, Galimand M, Duval J, Courvalin P: Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145. Antimicrob Agents Chemother. 1993 Oct;37(10):2119-25.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2285

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
23650

# Drug_Target_1_Name:
Streptogramin A acetyltransferase

# Drug_Target_1_Number_of_Residues:
209

# Drug_Target_1_PDB_ID:
1MR7

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00132	Hexapep

# Drug_Target_1_Protein_Sequence:
>Streptogramin A acetyltransferase
MGPNPMKMYPIEGNKSVQFIKPILEKLENVEVGEYSYYDSKNGETFDKQILYHYPILNDK
LKIGKFCSIGPGVTIIMNGANHRMDGSTYPFNLFGNGWEKHMPKLDQLPIKGDTIIGNDV
WIGKDVVIMPGVKIGDGAIVAANSVVVKDIAPYMLAGGNPANEIKQRFDQDTINQLLDIK
WWNWPIDIINENIDKILDNSIIREVIWKK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Inactivates the A compounds of streptogramin antibiotics by acetylation, thus providing resistance to these antibiotics

# Drug_Target_1_SwissProt_ID:
P50870

# Drug_Target_1_SwissProt_Name:
VATD_ENTFC

# Drug_Target_1_Synonyms:
EC 2.3.1.-
Vat(D)
Virginiamycin acetyltransferase D

# Drug_Target_1_Theoretical_pI:
5.75

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01669
